Logo image of 5Q5.DE

SNOWFLAKE INC (5Q5.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:5Q5 - US8334451098 - Common Stock

184.16 EUR
-3 (-1.6%)
Last: 12/11/2025, 7:00:00 PM
Fundamental Rating

4

5Q5 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 77 industry peers in the IT Services industry. 5Q5 has a bad profitability rating. Also its financial health evaluation is rather negative. 5Q5 is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 5Q5 was profitable.
In the past year 5Q5 had a positive cash flow from operations.
In the past 5 years 5Q5 always reported negative net income.
5Q5 had a positive operating cash flow in 4 of the past 5 years.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

5Q5's Return On Assets of -16.40% is on the low side compared to the rest of the industry. 5Q5 is outperformed by 88.31% of its industry peers.
5Q5 has a worse Return On Equity (-63.27%) than 84.42% of its industry peers.
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

With a Gross Margin value of 66.95%, 5Q5 perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
In the last couple of years the Gross Margin of 5Q5 has grown nicely.
The Profit Margin and Operating Margin are not available for 5Q5 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 5Q5 remains at a similar level compared to 1 year ago.
5Q5 has more shares outstanding than it did 5 years ago.
5Q5 has a worse debt/assets ratio than last year.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

5Q5 has a debt to FCF ratio of 2.96. This is a good value and a sign of high solvency as 5Q5 would need 2.96 years to pay back of all of its debts.
5Q5's Debt to FCF ratio of 2.96 is in line compared to the rest of the industry. 5Q5 outperforms 57.14% of its industry peers.
5Q5 has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
5Q5's Debt to Equity ratio of 1.07 is on the low side compared to the rest of the industry. 5Q5 is outperformed by 67.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Altman-Z N/A
ROIC/WACCN/A
WACC8.7%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

5Q5 has a Current Ratio of 1.37. This is a normal value and indicates that 5Q5 is financially healthy and should not expect problems in meeting its short term obligations.
5Q5 has a Current ratio of 1.37. This is in the better half of the industry: 5Q5 outperforms 64.94% of its industry peers.
5Q5 has a Quick Ratio of 1.37. This is a normal value and indicates that 5Q5 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, 5Q5 is in the better half of the industry, outperforming 68.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.53% over the past year.
5Q5 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 334.45% yearly.
Looking at the last year, 5Q5 shows a very strong growth in Revenue. The Revenue has grown by 28.48%.
5Q5 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.78% yearly.
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%

3.2 Future

The Earnings Per Share is expected to grow by 39.35% on average over the next years. This is a very strong growth
5Q5 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.67% yearly.
EPS Next Y48.98%
EPS Next 2Y42.71%
EPS Next 3Y42.87%
EPS Next 5Y39.35%
Revenue Next Year27.97%
Revenue Next 2Y25.81%
Revenue Next 3Y25.12%
Revenue Next 5Y23.67%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

5Q5 is valuated quite expensively with a Price/Earnings ratio of 173.74.
Based on the Price/Earnings ratio, 5Q5 is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.76. 5Q5 is valued rather expensively when compared to this.
5Q5 is valuated quite expensively with a Price/Forward Earnings ratio of 129.18.
Based on the Price/Forward Earnings ratio, 5Q5 is valued a bit more expensive than 70.13% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.96. 5Q5 is valued rather expensively when compared to this.
Industry RankSector Rank
PE 173.74
Fwd PE 129.18
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of 5Q5 indicates a slightly more expensive valuation: 5Q5 is more expensive than 68.83% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 95
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 5Q5 does not grow enough to justify the current Price/Earnings ratio.
5Q5's earnings are expected to grow with 42.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.55
PEG (5Y)N/A
EPS Next 2Y42.71%
EPS Next 3Y42.87%

0

5. Dividend

5.1 Amount

5Q5 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SNOWFLAKE INC

FRA:5Q5 (12/11/2025, 7:00:00 PM)

184.16

-3 (-1.6%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)12-03 2025-12-03/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners74.32%
Inst Owner ChangeN/A
Ins Owners2.41%
Ins Owner ChangeN/A
Market Cap62.39B
Revenue(TTM)4.39B
Net Income(TTM)-1.35B
Analysts81.79
Price Target246.13 (33.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.9%
Min EPS beat(2)10.63%
Max EPS beat(2)29.18%
EPS beat(4)4
Avg EPS beat(4)29.73%
Min EPS beat(4)10.37%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)28.63%
EPS beat(12)11
Avg EPS beat(12)66.06%
EPS beat(16)14
Avg EPS beat(16)111.07%
Revenue beat(2)2
Avg Revenue beat(2)1.9%
Min Revenue beat(2)0.66%
Max Revenue beat(2)3.15%
Revenue beat(4)4
Avg Revenue beat(4)1.62%
Min Revenue beat(4)0.66%
Max Revenue beat(4)3.15%
Revenue beat(8)8
Avg Revenue beat(8)1.61%
Revenue beat(12)11
Avg Revenue beat(12)1.2%
Revenue beat(16)15
Avg Revenue beat(16)1.34%
PT rev (1m)4.08%
PT rev (3m)20.97%
EPS NQ rev (1m)-5.9%
EPS NQ rev (3m)-4.52%
EPS NY rev (1m)0.05%
EPS NY rev (3m)8.03%
Revenue NQ rev (1m)1.35%
Revenue NQ rev (3m)1.59%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE 173.74
Fwd PE 129.18
P/S 16.66
P/FCF 95
P/OCF 83.67
P/B 34.27
P/tB 104.2
EV/EBITDA N/A
EPS(TTM)1.06
EY0.58%
EPS(NY)1.43
Fwd EY0.77%
FCF(TTM)1.94
FCFY1.05%
OCF(TTM)2.2
OCFY1.2%
SpS11.05
BVpS5.37
TBVpS1.77
PEG (NY)3.55
PEG (5Y)N/A
Graham Number11.32
Profitability
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.95%
FCFM 17.54%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Debt/EBITDA N/A
Cap/Depr 49.21%
Cap/Sales 2.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z N/A
F-Score4
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)67.21%
Cap/Depr(5y)189.07%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y48.98%
EPS Next 2Y42.71%
EPS Next 3Y42.87%
EPS Next 5Y39.35%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%
Revenue Next Year27.97%
Revenue Next 2Y25.81%
Revenue Next 3Y25.12%
Revenue Next 5Y23.67%
EBIT growth 1Y-4.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.67%
EBIT Next 3Y83.12%
EBIT Next 5Y65.79%
FCF growth 1Y21.94%
FCF growth 3Y149.6%
FCF growth 5YN/A
OCF growth 1Y21.18%
OCF growth 3Y105.76%
OCF growth 5YN/A

SNOWFLAKE INC / 5Q5.DE FAQ

What is the fundamental rating for 5Q5 stock?

ChartMill assigns a fundamental rating of 4 / 10 to 5Q5.DE.


Can you provide the valuation status for SNOWFLAKE INC?

ChartMill assigns a valuation rating of 1 / 10 to SNOWFLAKE INC (5Q5.DE). This can be considered as Overvalued.


How profitable is SNOWFLAKE INC (5Q5.DE) stock?

SNOWFLAKE INC (5Q5.DE) has a profitability rating of 2 / 10.


What are the PE and PB ratios of SNOWFLAKE INC (5Q5.DE) stock?

The Price/Earnings (PE) ratio for SNOWFLAKE INC (5Q5.DE) is 173.74 and the Price/Book (PB) ratio is 34.27.


Can you provide the expected EPS growth for 5Q5 stock?

The Earnings per Share (EPS) of SNOWFLAKE INC (5Q5.DE) is expected to grow by 48.98% in the next year.